🔊CEOInterviews

Joe Brew on business model

From Riderflex Podcast - Guest Interview #399 - Joe Brew · · Riderflex

“Our revenue model is B2B: we license our cough detection and analysis algorithms and platforms to researchers, pharmaceutical companies running trials, and remote patient monitoring providers — the consumer cough tracker app in the U.S. is free and will remain free.”

Joe Brew
Cofounder, Hyfe
Policy Impact business modeldigital health commercializationpharma

On , Joe Brew, Cofounder at Hyfe, spoke about business model during Riderflex Podcast - Guest Interview #399 - Joe Brew on Riderflex.

Riderflex Podcast - Guest Interview #399 - Joe Brew
Watch on YouTube
Riderflex Podcast - Guest Interview #399 - Joe Brew
Riderflex
Watch on YouTube
Joe Brew is a data scientist with a background in public health. Joe has worked in infectious disease control surveillance, ...
Joe Brew

About Joe Brew

Cofounder · Hyfe

Joe Brew, cofounder and CEO of Hyfe, has been discussing the company's cough-tracking technology in several interviews and explainer videos. He described how the CoughPro app uses a phone's microphone to detect explosive sounds, saves a 0.5-second audio clip, and categorizes it as cough or non-cough using an on-device AI model. Brew stated that the audio is processed locally and deleted immediately, with only the timestamp of a detected cough being saved. He compared the app's listening behavior to voice assistants like Siri or Alexa, saying it listens only for cough-like sounds rather than recording general audio. In podcast appearances, Brew discussed Hyfe's focus on cough as a prevalent symptom across chronic conditions and infectious diseases. He noted that the company initially developed the app for COVID-19 monitoring but found that chronic cough patients became the primary users. Brew described Hyfe's business model as B2B, licensing its algorithms to researchers and pharmaceutical companies, while keeping the consumer app free. He also mentioned conducting validation trials and having pre-submission meetings with the FDA regarding medical clearance. Brew expressed interest in using acoustic data for early outbreak detection and tuberculosis screening, and he emphasized the importance of measuring cough objectively rather than relying on patient self-reporting.

Profile compiled from Joe Brew's verified public interviews and appearances. See all quotes & transcripts →

More from Joe Brew Full Transcript Explore All Executives